Strategic Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$847K |
| 2 |
Blackstone Mortgage Trust
BXMT
|
+$788K |
| 3 |
Procter & Gamble
PG
|
+$678K |
| 4 |
Chevron
CVX
|
+$660K |
| 5 |
Medtronic
MDT
|
+$586K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PIMCO Active Bond Exchange-Traded Fund
BOND
|
+$8.44M |
| 2 |
Merck
MRK
|
+$7.44M |
| 3 |
Abbott
ABT
|
+$1.24M |
| 4 |
Yum! Brands
YUM
|
+$1.17M |
| 5 |
Qualcomm
QCOM
|
+$1.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 18.05% |
| 2 | Technology | 17.71% |
| 3 | Healthcare | 14.16% |
| 4 | Financials | 8.88% |
| 5 | Consumer Discretionary | 8.42% |
Similar funds
Strategic Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, Strategic Advisors held 207 positions worth $449M, down 0.45% from $451M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Strategic Advisors withdrew a net $25.2M in Q4 2022, closing 12 positions and reducing 103 holdings. Its most notable exit was PIMCO Active Bond Exchange-Traded Fund, an estimated $8.44M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Strategic Advisors opened a new position in Gilead Sciences worth $919K.
- Strategic Advisors's largest Q4 2022 buy was Gilead Sciences: 10,700 shares worth $919K.
- Strategic Advisors added most to Procter & Gamble in Q4 2022, an estimated $678K increase.
- Strategic Advisors's biggest Q4 2022 reduction was Merck, cutting an estimated $7.44M.
- Strategic Advisors fully exited PIMCO Active Bond Exchange-Traded Fund in Q4 2022, selling an estimated $8.44M.
- Strategic Advisors's ten largest holdings make up 37% of its $449M portfolio in Q4 2022.
- Strategic Advisors opened 11 new positions and closed 12 in Q4 2022.
- Strategic Advisors's portfolio value fell 0.45% quarter-over-quarter to $449M.
Based on Strategic Advisors's 13F filing for Q4 2022, filed 23 Jan 2023.